These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 39264078)
1. Linc-ROR Modulates the Endothelial-Mesenchymal Transition of Endothelial Progenitor Cells through the miR-145/Smad3 Signaling Pathway. Liang J; Chu H; Ran Y; Lin R; Cai Y; Guan X; Cui X; Zhang X; Li H; Cheng M Physiol Res; 2024 Aug; 73(4):565-576. PubMed ID: 39264078 [TBL] [Abstract][Full Text] [Related]
2. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
3. Linc-ROR targets FGF2 to regulate HASMC proliferation and migration via sponging miR-195-5p. Ji Z; Chi J; Sun H; Ru A; Ni T; Zhang J; Jiang F; Lv H; Peng F; Guo H; Chen Y Gene; 2020 Jan; 725():144143. PubMed ID: 31629816 [TBL] [Abstract][Full Text] [Related]
4. Linc-ROR Promotes EMT by Targeting miR-204-5p/SMAD4 in Endometriosis. Yi M; Wang S; Zhang X; Jiang L; Xia X; Zhang T; Fang X Reprod Sci; 2023 Sep; 30(9):2665-2679. PubMed ID: 36917423 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536 [TBL] [Abstract][Full Text] [Related]
6. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition. Liu M; Zhang M; Yin H Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480 [TBL] [Abstract][Full Text] [Related]
7. Linc-ROR promotes mesenchymal stem cells chondrogenesis and cartilage formation via regulating SOX9 expression. Feng L; Yang ZM; Li YC; Wang HX; Lo JHT; Zhang XT; Li G Osteoarthritis Cartilage; 2021 Apr; 29(4):568-578. PubMed ID: 33485931 [TBL] [Abstract][Full Text] [Related]
8. microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway. Zhang J; Zhang Z; Zhang DY; Zhu J; Zhang T; Wang C PLoS One; 2013; 8(12):e83294. PubMed ID: 24349482 [TBL] [Abstract][Full Text] [Related]
9. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462 [TBL] [Abstract][Full Text] [Related]
10. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells. Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251 [TBL] [Abstract][Full Text] [Related]
11. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-221 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PTEN/FoxO3a signaling pathway. Zhou E; Zou Y; Mao C; Li D; Wang C; Zhang Z Adv Clin Exp Med; 2021 Dec; 30(12):1263-1270. PubMed ID: 34610220 [TBL] [Abstract][Full Text] [Related]
13. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2. Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998 [TBL] [Abstract][Full Text] [Related]
14. The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2. Li C; Lu L; Feng B; Zhang K; Han S; Hou D; Chen L; Chu X; Wang R Sci Rep; 2017 Jul; 7(1):4637. PubMed ID: 28680141 [TBL] [Abstract][Full Text] [Related]
15. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway. Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051 [TBL] [Abstract][Full Text] [Related]
16. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Chen YM; Liu Y; Wei HY; Lv KZ; Fu P Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251 [TBL] [Abstract][Full Text] [Related]
17. lncRNA ZFAS1 promotes ox-LDL induced EndMT through miR-150-5p/Notch3 signaling axis. Yin Q; He M; Huang L; Zhang X; Zhan J; Hu J Microvasc Res; 2021 Mar; 134():104118. PubMed ID: 33278458 [TBL] [Abstract][Full Text] [Related]
18. Long intergenic noncoding RNA smad7 (Linc-smad7) promotes the epithelial-mesenchymal transition of HCC by targeting the miR-125b/SIRT6 axis. Han L; Jia L; Zan Y Cancer Med; 2020 Dec; 9(23):9123-9137. PubMed ID: 33037850 [TBL] [Abstract][Full Text] [Related]
19. LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway. Sun LL; Lei FR; Jiang XD; Du XL; Xiao L; Li WD; Li XQ Aging (Albany NY); 2020 Mar; 12(5):4506-4526. PubMed ID: 32156832 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. Meng S; Cao J; Zhang X; Fan Y; Fang L; Wang C; Lv Z; Fu D; Li Y PLoS One; 2013; 8(7):e68611. PubMed ID: 23874686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]